Literature DB >> 35103109

Clinical biomedical research of indoleamine 2,3-dioxygenase: update on current available reports from Southeast Asia.

Beuy Joob1, Sora Yasri2, Viroj Wiwanitkit3.   

Abstract

Indoleamine 2,3-dioxygenase is an important enzyme in human, which plays roles in the rate-limiting first step in tryptophan catabolism. Indoleamine 2,3-dioxygenase is currently studied by research groups worldwide. Association between Indoleamine 2,3-dioxygenase and medial disorders in clinical medicine is proposed and is an interesting topic in clinical biochemical reasearch. Here, the author briefly reviews and discusses on the available important scientific reports on Indoleamine 2,3-dioxygenase from tropical Southeast Asia. IJBMB
Copyright © 2021.

Entities:  

Keywords:  3-dioxygenase; Indochina; Indoleamine 2; analysis

Year:  2021        PMID： 35103109      PMCID： PMC8784796     

Source DB:  PubMed          Journal:  Int J Biochem Mol Biol        ISSN： 2152-4114


  30 in total

1.  IL-8 and IDO expression by human gingival fibroblasts via TLRs.

Authors:  Rangsini Mahanonda; Noppadol Sa-Ard-Iam; Pattanin Montreekachon; Atiphan Pimkhaokham; Kosol Yongvanichit; Mark M Fukuda; Sathit Pichyangkul
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

Review 2.  [Indoleamine 2,3-dioxygenase in oncology and psychiatry].

Authors:  Vladimír Vonka; Jiří Horáček
Journal:  Cas Lek Cesk       Date:  2015

Review 3.  Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy.

Authors:  Sarah Yentz; David Smith
Journal:  BioDrugs       Date:  2018-08       Impact factor: 5.807

Review 4.  Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients.

Authors:  Michael Maes; Piyanuj Ruckoanich; Young Seun Chang; Nithi Mahanonda; Michael Berk
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-06-16       Impact factor: 5.067

5.  Decreased indoleamine 2,3-dioxygenase activity and IL-10/IL-17A ratio in patients with COPD.

Authors:  Kittipong Maneechotesuwan; Kanda Kasetsinsombat; Adisak Wongkajornsilp; Peter J Barnes
Journal:  Thorax       Date:  2012-12-19       Impact factor: 9.139

6.  Effects of IL-17 on human gingival fibroblasts.

Authors:  R Mahanonda; P Jitprasertwong; N Sa-Ard-Iam; P Rerkyen; O Charatkulangkun; P Jansisyanont; K Nisapakultorn; K Yongvanichit; S Pichyangkul
Journal:  J Dent Res       Date:  2008-03       Impact factor: 6.116

7.  Sputum indoleamine-2, 3-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids.

Authors:  Kittipong Maneechotesuwan; Sirinya Supawita; Kanda Kasetsinsombat; Adisak Wongkajornsilp; Peter J Barnes
Journal:  J Allergy Clin Immunol       Date:  2007-11-26       Impact factor: 10.793

8.  Indoleamine 2,3-dioxygenase expression and regulation in chronic periodontitis.

Authors:  Kanokwan Nisapakultorn; Jittima Makrudthong; Noppadol Sa-Ard-Iam; Pimprapa Rerkyen; Rangsini Mahanonda; Osamu Takikawa
Journal:  J Periodontol       Date:  2009-01       Impact factor: 6.993

9.  Neopterin levels and Kyn/Trp ratios were significantly increased in dengue virus patients and subsequently decreased after recovery.

Authors:  Simon Geisler; Simon D Lytton; Nguyen Linh Toan; Trinh Huu Nghia; Nguyen Minh Nam; Hoang Vu Hung; Nguyen Thai Son; Do Tuan Anh; Hoang Tien Tuyen; Tran Viet Tien; Do Quyet; Hoang Van Tong; Nghiem Xuan Hoan; Le Huu Song; Srinivas Reddy Pallerla; Johanna M Gostner; Dietmar Fuchs; Thirumalaisamy P Velavan
Journal:  Int J Infect Dis       Date:  2019-12-09       Impact factor: 3.623

10.  The extracts of Astragalus membranaceus enhance chemosensitivity and reduce tumor indoleamine 2, 3-dioxygenase expression.

Authors:  Naphichaya Phacharapiyangkul; Li-Hsien Wu; Wei-Ya Lee; Yi-Hsuan Kuo; Yueh-Jung Wu; Huei-Pu Liou; Yung-En Tsai; Che-Hsin Lee
Journal:  Int J Med Sci       Date:  2019-08-06       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.